Abstract:MicroRNAs (miRNAs) are small, non-coding regulatory RNAs that post-transcriptionally regulate gene expression. These conserved molecules are highly expressed in the brain, being essential for neuronal function and survival. miRNA profiles are significantly altered in Alzheimer's disease (AD) patient brains. We have previously shown that tauroursodeoxycholic acid (TUDCA) is a strong neuroprotective agent in several AD experimental models. In addition, bile acids modulate both mRNA and miRNA expression in the rat liver. Nevertheless, the therapeutic role of TUDCA in AD pathology has not yet been ascertained. The present study was designed to identify miRNAs differentially expressed in wild-type and APP/PS1 transgenic mice, as well as elucidate the role of TUDCA in modulating miRNAs potentially associated with AD. We carried out highly sensitive expression profiling of 1140 miRNAs on samples obtained from the hippocampus and frontal cortex of male APP/PS1 transgenic mice and wild-type littermates fed diets containing 0.4 percent TUDCA, or no bile acid, for 6 months. Validation was performed by qRT-PCR. APP/PS1 mice brains showed significant and large fold-change differential expression of 46 miRNAs including miR-295, -302c, -599, and -615, relative to wild-type mice. In addition, significant differences were also detected in 28 miRNAs in the direct comparison of untreated and TUDCA-treated APP/PS1 mice. Finally, in silico analysis identified putative target genes for specific miRNAs deregulated in APP/PS1 mice and modulated by TUDCA. Pathway enrichment within these putative targets revealed that miRNAs found altered in APP/PS1 mice are potentially involved in axon guidance mechanisms, long-term potentiation and/or depression, glutamate metabolism, and apoptosis. Interestingly, amyloid precursor protein (APP) 3'UTR is potentially targeted by miR-295, which expression was significantly decreased in the cortex of APP/PS1 mice. In contrast, miR-599 was upregulated in the brain of APP/PS1 mice and potentially targets the low-density lipoprotein (LDL) receptor-related protein 6 (LRP6) 3'UTR involved in Aβ clearance. Notably, miR-599 expression was decreased by TUDCA. miRNA profiling of APP/PS1 mice provides an appealing approach to address how changes in miRNA profiles translate into biological functions in AD pathological context. Modulation of AD-associated miRNAs by TUDCA may represent a potential therapeutic strategy for prevention and treatment of the disease.

HuD Regulates Coding and Noncoding RNA to Induce APP→Aβ Processing.

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Exosomes Mediate APP Dysregulation <i>via</i> APP-miR-185-5p Axis

HDAC3 Negatively Regulates Spatial Memory in a Mouse Model of Alzheimer's Disease.

DEAD-Box Helicase 17 Promotes Amyloidogenesis by Regulating BACE1 Translation

Apolipoprotein D Modulates Amyloid Pathology in APP/PS1 Alzheimer's Disease Mice

Spatiotemporal Activation Of The C/Ebp Beta/Delta-Secretase Axis Regulates The Pathogenesis Of Alzheimer'S Disease

Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E

Upregulation of Divalent Metal Transporter 1 (DMT1) is Involved in Amyloid Precursor Protein Processing and Aβ Generation

Ubiquitin Hydrolase Uch-L1 Rescues Β-Amyloid-induced Decreases in Synaptic Function and Contextual Memory

Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

HuD Regulates the Cpg15 Expression Via the 3′-UTR and AU-Rich Element

Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing

P3‐046: Understanding Brain Microrna Profiling in the Double Transgenic APP/PS1 Mouse Model of Alzheimer's Disease

In-depth transcriptomic analyses of LncRNA and mRNA expression in the hippocampus of APP/PS1 mice by Danggui-Shaoyao-San

The Role of Copper and the Copper-Related Protein CUTA in Mediating APP Processing and Aβ Generation

Delta-secretase Triggers Alzheimer's Disease Pathologies in Wild-Type Happ/hmapt Double Transgenic Mice.

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

APP and its intracellular domain modulate Alzheimer’s disease risk gene networks in transgenic and porcine models

AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice

AβPP-tau-HAS1 axis trigger HAS1-related nuclear speckles and gene transcription in Alzheimer's disease